BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meunier C, Merienne N, Jollé C, Déglon N, Pellerin L. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease. Glia 2016;64:1841-56. [PMID: 27442486 DOI: 10.1002/glia.23022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Andersen JV, Schousboe A. Glial Glutamine Homeostasis in Health and Disease. Neurochem Res 2022. [DOI: 10.1007/s11064-022-03771-1] [Reference Citation Analysis]
2 Lim RG, Al-dalahmah O, Wu J, Gold MP, Reidling JC, Tang G, Adam M, Dansu D, Park H, Casaccia P, Miramontes R, Reyes-ortiz AM, Lau A, Khan F, Paryani F, Tang A, Ofori K, Miyoshi E, Michael N, Geller N, Flowers XE, Vonsattel JP, Davidson S, Menon V, Swarup V, Fraenkel E, Goldman JE, Thompson LM. Single nuclei RNAseq analysis of HD mouse models and human brain reveals impaired oligodendrocyte maturation and potential role for thiamine metabolism.. [DOI: 10.1101/2022.06.27.497613] [Reference Citation Analysis]
3 Smethurst P, Franklin H, Clarke BE, Sidle K, Patani R. The role of astrocytes in prion-like mechanisms of neurodegeneration. Brain 2022:awab366. [PMID: 35265969 DOI: 10.1093/brain/awab366] [Reference Citation Analysis]
4 Hirschberg S, Dvorzhak A, Rasooli-nejad SMA, Angelov S, Kirchner M, Mertins P, Lättig-tünnemann G, Harms C, Schmitz D, Grantyn R. Uncoupling the Excitatory Amino Acid Transporter 2 From Its C-Terminal Interactome Restores Synaptic Glutamate Clearance at Corticostriatal Synapses and Alleviates Mutant Huntingtin-Induced Hypokinesia. Front Cell Neurosci 2022;15:792652. [DOI: 10.3389/fncel.2021.792652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim C, Yousefian-Jazi A, Choi SH, Chang I, Lee J, Ryu H. Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease. Int J Mol Sci 2021;22:12499. [PMID: 34830381 DOI: 10.3390/ijms222212499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Duarte Azevedo M, Sander S, Jeanneret C, Olfat S, Tenenbaum L. Selective targeting of striatal parvalbumin-expressing interneurons for transgene delivery. J Neurosci Methods 2021;354:109105. [PMID: 33652020 DOI: 10.1016/j.jneumeth.2021.109105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Odo T, Okamoto T, Sato N, Takahashi Y. Blended phenotype of adult-onset Alexander disease and spinocerebellar ataxia type 6. Neurol Genet 2020;6:e522. [PMID: 33134518 DOI: 10.1212/NXG.0000000000000522] [Reference Citation Analysis]
8 Hirschberg S, Dvorzhak A, Rasooli-nejad SMA, Angelov S, Kirchner M, Mertins P, Lättig-tünnemann G, Harms C, Schmitz D, Grantyn R. Expression of a modified astrocytic glutamate transporter alleviates Huntington’s hypokinesia, promotes synaptic glutamate clearance and counteracts potentially adverse EAAT2 interactions.. [DOI: 10.1101/2020.09.17.302158] [Reference Citation Analysis]
9 Creus-Muncunill J, Ehrlich ME. Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models. Neurotherapeutics 2019;16:957-78. [PMID: 31529216 DOI: 10.1007/s13311-019-00782-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
10 Humbel M, Ramosaj M, Zimmer V, Regio S, Aeby L, Moser S, Boizot A, Sipion M, Rey M, Déglon N. Maximizing lentiviral vector gene transfer in the CNS. Gene Ther 2021;28:75-88. [PMID: 32632267 DOI: 10.1038/s41434-020-0172-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
11 Maxan A, Sciacca G, Alpaugh M, Tao Z, Breger L, Dehay B, Ling Z, Chuan Q, Cisbani G, Masnata M, Salem S, Lacroix S, Oueslati A, Bezard E, Cicchetti F. Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates. Neurobiol Dis 2020;141:104951. [PMID: 32439599 DOI: 10.1016/j.nbd.2020.104951] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
12 Sardella E, Mola MG, Gristina R, Piccione M, Veronico V, Bellis M, Cibelli A, Buttiglione M, Armenise V, Favia P, Nicchia GP. A Synergistic Effect of Reactive Oxygen and Reactive Nitrogen Species in Plasma Activated Liquid Media Triggers Astrocyte Wound Healing. Int J Mol Sci 2020;21:E3343. [PMID: 32397300 DOI: 10.3390/ijms21093343] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
13 Merienne N, Meunier C, Schneider A, Seguin J, Nair SS, Rocher AB, Le Gras S, Keime C, Faull R, Pellerin L, Chatton JY, Neri C, Merienne K, Déglon N. Cell-Type-Specific Gene Expression Profiling in Adult Mouse Brain Reveals Normal and Disease-State Signatures. Cell Rep 2019;26:2477-2493.e9. [PMID: 30811995 DOI: 10.1016/j.celrep.2019.02.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 22.5] [Reference Citation Analysis]
14 Blumenstock S, Dudanova I. Cortical and Striatal Circuits in Huntington's Disease. Front Neurosci 2020;14:82. [PMID: 32116525 DOI: 10.3389/fnins.2020.00082] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 16.5] [Reference Citation Analysis]
15 Hirbec H, Déglon N, Foo LC, Goshen I, Grutzendler J, Hangen E, Kreisel T, Linck N, Muffat J, Regio S, Rion S, Escartin C. Emerging technologies to study glial cells. Glia 2020;68:1692-728. [PMID: 31958188 DOI: 10.1002/glia.23780] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
16 Kery R, Chen APF, Kirschen GW. Genetic targeting of astrocytes to combat neurodegenerative disease. Neural Regen Res 2020;15:199-211. [PMID: 31552885 DOI: 10.4103/1673-5374.265541] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
17 Gray M. Astrocytes in Huntington's Disease. Adv Exp Med Biol 2019;1175:355-81. [PMID: 31583595 DOI: 10.1007/978-981-13-9913-8_14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
18 Stanek LM, Bu J, Shihabuddin LS. Astrocyte transduction is required for rescue of behavioral phenotypes in the YAC128 mouse model with AAV-RNAi mediated HTT lowering therapeutics. Neurobiology of Disease 2019;129:29-37. [DOI: 10.1016/j.nbd.2019.04.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
19 Jollé C, Déglon N, Pythoud C, Bouzier-Sore AK, Pellerin L. Development of Efficient AAV2/DJ-Based Viral Vectors to Selectively Downregulate the Expression of Neuronal or Astrocytic Target Proteins in the Rat Central Nervous System. Front Mol Neurosci 2019;12:201. [PMID: 31481874 DOI: 10.3389/fnmol.2019.00201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
20 Ruiz-Calvo A, Bajo-Grañeras R, Maroto IB, Zian D, Grabner GF, García-Taboada E, Resel E, Zechner R, Zimmermann R, Ortega-Gutiérrez S, Galve-Roperh I, Bellocchio L, Guzmán M. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons. Neuropharmacology 2019;150:134-44. [PMID: 30914306 DOI: 10.1016/j.neuropharm.2019.03.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
21 Yeh PA, Liu YH, Chu WC, Liu JY, Sun YH. Glial expression of disease-associated poly-glutamine proteins impairs the blood-brain barrier in Drosophila. Hum Mol Genet 2018;27:2546-62. [PMID: 29726932 DOI: 10.1093/hmg/ddy160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
22 Dvorzhak A, Helassa N, Török K, Schmitz D, Grantyn R. Single Synapse Indicators of Impaired Glutamate Clearance Derived from Fast iGlu u Imaging of Cortical Afferents in the Striatum of Normal and Huntington (Q175) Mice. J Neurosci 2019;39:3970-82. [PMID: 30819797 DOI: 10.1523/JNEUROSCI.2865-18.2019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
23 Ruiz-Calvo A, Maroto IB, Bajo-Grañeras R, Chiarlone A, Gaudioso Á, Ferrero JJ, Resel E, Sánchez-Prieto J, Rodríguez-Navarro JA, Marsicano G, Galve-Roperh I, Bellocchio L, Guzmán M. Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors. Cereb Cortex 2018;28:307-22. [PMID: 29121220 DOI: 10.1093/cercor/bhx285] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
24 Kim JH, Lukowicz A, Qu W, Johnson A, Cvetanovic M. Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage-of-disease specific manner. Glia 2018;66:1972-87. [PMID: 30043530 DOI: 10.1002/glia.23451] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
25 Dvorzhak A, Melnick I, Grantyn R. Astrocytes and presynaptic plasticity in the striatum: Evidence and unanswered questions. Brain Research Bulletin 2018;136:17-25. [DOI: 10.1016/j.brainresbull.2017.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
26 Khakh BS, Beaumont V, Cachope R, Munoz-Sanjuan I, Goldman SA, Grantyn R. Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease. Trends Neurosci 2017;40:422-37. [PMID: 28578789 DOI: 10.1016/j.tins.2017.05.002] [Cited by in Crossref: 104] [Cited by in F6Publishing: 90] [Article Influence: 20.8] [Reference Citation Analysis]
27 Rattray I, Smith EJ, Crum WR, Walker TA, Gale R, Bates GP, Modo M. Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's Disease. PLoS One 2017;12:e0168556. [PMID: 28099507 DOI: 10.1371/journal.pone.0168556] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
28 Gowing G, Svendsen S, Svendsen CN. Ex vivo gene therapy for the treatment of neurological disorders. Prog Brain Res 2017;230:99-132. [PMID: 28552237 DOI: 10.1016/bs.pbr.2016.11.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]